Fertility and Sterility
Volume 93, Issue 1 , Pages 52-56 , 1 January 2010

Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial

Received 9 July 2008 ,Revised 28 August 2008 ,Accepted 14 September 2008.

References 

  1. Liu X, Yuan L, Shen F, Zhu Z, Jiang H, Guo SW. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol. 2007;109:1411–1420
  2. Chapron C, Vercellini P, Barakat H, Vieira M, Dubuisson JB. Management of ovarian endometriomas. Hum Reprod Update. 2002;8:591–597
  3. Fedele L, Bianchi S, Zanconato G, Berlanda N, Raffaelli R, Fontana E. Laparoscopic excision of recurrent endometriomas: long-term outcome and comparison with primary surgery. Fertil Steril. 2006;85:694–699
  4. Jones KD, Sutton CJ. Laparoscopic management of ovarian endometriomas: a critical review of current practice. [review] Curr Opin Obstet Gynecol. 2000;12:309–315
  5. Busacca M, Marana R, Caruana P, Candiani M, Muzii L, Calia C, et al. Recurrence of ovarian endometrioma after laparoscopic excision. Am J Obstet Gynecol. 1999;180:519–523
  6. Koga K, Takemura Y, Osuga Y, Yoshino O, Hirota Y, Hirata T, et al. Recurrence of ovarian endometrioma after laparoscopic excision. Hum Reprod. 2006;21:2171–2174
  7. Jones KD, Sutton CJ. Recurrence of chocolate cysts after laparoscopic ablation. J Am Assoc Gynecol Laparosc. 2002;9:315–320
  8. Prentice A. Regular review: Endometriosis. BMJ. 2001;323:93–95
  9. Vercellini P, Somigliana E, Viganò P, Abbiati A, Daguati R, Crosignani PG. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol. 2008;22:275–306
  10. Muzii L, Marana R, Caruana P, Catalano GF, Margutti F, Panici PB. Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial. Am J Obstet Gynecol. 2000;183:588–592
  11. Vercellini P, Somigliana E, Daguati R, Vigano P, Meroni F, Crosignani PG. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol. 2008;198:504.e1–504.e5
  12. Crosignani P, Olive D, Bergqvist A, Luciano A. Advances in the management of endometriosis: an update for clinicians. [review] Hum Reprod Update. 2006;12:179–189
  13. Marana R, Caruana P, Muzii L, Catalano GF, Mancuso S. Operative laparoscopy for ovarian cysts. Excision vs. aspiration. J Reprod Med. 1996;41:435–438
  14. The American Fertility Society . Revised American Fertility Society classification of endometriosis. Fertil Steril. 1985;43:351–352
  15. Exacoustos C, Zupi E, Carusotti C, Rinaldo D, Marconi D, Lanzi G, et al. Staging of pelvic endometriosis: role of sonographic appearance in determining extension of disease and modulating surgical approach. J Am Assoc Gynecol Laparosc. 2003;10:378–382
  16. Meresman GF, Augè L, Baranao RI, Lombardi E, Tesone M, Sueldo C. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril. 2002;77:1141–1147
  17. Jain S, Dalton ME. Chocolate cysts from ovarian follicles. Fertil Steril. 1999;72:852–856
  18. Vercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasini R, Crosignani PG. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril. 2003;80:560–563
  19. Moore J, Copley S, Morris J, Lindsell D, Golding S, Kennedy S. A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis. [review] Ultrasound Obstet Gynecol. 2002;20:630–634

 R.S. has nothing to disclose. M.M. has nothing to disclose. C.F. has nothing to disclose. L.M. has nothing to disclose. G.M. has nothing to disclose. A.K. has nothing to disclose. S.V. has nothing to disclose.

PII: S0015-0282(08)03949-6

doi: 10.1016/j.fertnstert.2008.09.052

Fertility and Sterility
Volume 93, Issue 1 , Pages 52-56 , 1 January 2010

Article Tools

* Image Usage & Resolution